Page last updated: 2024-08-24

zanamivir and Pneumonia, Viral

zanamivir has been researched along with Pneumonia, Viral in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (33.33)	29.6817
2010's	8 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calistri, A; Del Vecchio, C; Franchin, E; Marini, G; Nicolè, S; Palù, G; Parolin, C; Salata, C; Sgarabotto, D; Solimbergo, E	1
Chan, JF; Chan, KH; Cheng, VC; Ho, PL; Sin, WC	1
Chan, JF; Chen, H; Hung, IF; Lee, AC; Li, C; Li, L; To, KK; Wu, HW; Yuen, KY; Zhang, AJ; Zhu, H	1
Down, J; Grant, PR; Howell, DC; Kidd, IM; Nastouli, E; Shulman, R; Singer, M	1
Bilgin, H; Odabas, D; Sert, A; Yazar, A	1
Boyko, Y; Jensen, R; Nielsen, LP; Severinsen, IK; Storgaard, M; Terp, K	1
Reece, PA	1
Al'khovskiĭ, SV; Aristova, VA; Bazarova, MV; Burtseva, EI; Chuchalin, AG; Fediakina, IT; Kolobukhina, LV; Malyshev, NA; Maslov, AM; Merkulova, LN; Morozova, TN; Ponomarenko, RA; Prilipov, AG; Proshina, ES; Samokhvalov, EI; Shchelkanov, MIu; Sutochnikova, OA	1
Chan, K; Chua, YY; Cui, L; Tan, BH; Wijaya, L	1
Bazin, H; Cavallo, JD; Hernandez, E; Lhonneux, A; Noury, J; Ramisse, F	1
Ikematsu, H	1
Lorin, V; Manuguerra, JC; Medeiros, R; Naffakh, N; Rameix-Welti, MA; Ribaud, P; Scieux, C; Socie, G; van der Werf, S	1

Reviews

2 review(s) available for zanamivir and Pneumonia, Viral

Article	Year
Treatment options for H5N1: lessons learned from the H1N1 pandemic. Postgraduate medicine, 2010, Volume: 122, Issue:5 Topics: Acids, Carbocyclic; Antiviral Agents; Cyclopentanes; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Immunocompromised Host; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Pneumonia, Viral; Pyrans; Severity of Illness Index; Sialic Acids; Zanamivir	2010
[Clinical characteristic of the elderly in influenza infection]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:11 Topics: Age Factors; Aged; Amantadine; Antiviral Agents; Chromatography; Enzyme Inhibitors; Guanidines; Humans; Immunoenzyme Techniques; Influenza Vaccines; Influenza, Human; Neuraminidase; Pneumonia, Viral; Prognosis; Pyrans; Reagent Kits, Diagnostic; Risk; Sialic Acids; Zanamivir	2003

Article

Year

Treatment options for H5N1: lessons learned from the H1N1 pandemic.

Postgraduate medicine, 2010, Volume: 122, Issue:5

Topics: Acids, Carbocyclic; Antiviral Agents; Cyclopentanes; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Immunocompromised Host; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Pneumonia, Viral; Pyrans; Severity of Illness Index; Sialic Acids; Zanamivir

2010

[Clinical characteristic of the elderly in influenza infection].

Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:11

Topics: Age Factors; Aged; Amantadine; Antiviral Agents; Chromatography; Enzyme Inhibitors; Guanidines; Humans; Immunoenzyme Techniques; Influenza Vaccines; Influenza, Human; Neuraminidase; Pneumonia, Viral; Prognosis; Pyrans; Reagent Kits, Diagnostic; Risk; Sialic Acids; Zanamivir

2003

Other Studies

10 other study(ies) available for zanamivir and Pneumonia, Viral

Article	Year
Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:7 Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukemia, Lymphocytic, Chronic, B-Cell; Oseltamivir; Pneumonia, Viral; Treatment Outcome; Virus Shedding; Zanamivir	2019
Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir. The European respiratory journal, 2014, Volume: 44, Issue:2 Topics: Adult; Antiviral Agents; Female; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Pneumonia, Viral; Respiration Disorders; Time Factors; Treatment Outcome; Zanamivir	2014
Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PloS one, 2014, Volume: 9, Issue:9 Topics: Adaptation, Physiological; Animals; Antiviral Agents; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H7N9 Subtype; Lung; Mice; Mice, Inbred BALB C; Pneumonia, Viral; Virus Replication; Zanamivir	2014
H1N1 pneumonitis treated with intravenous zanamivir. Lancet (London, England), 2009, Sep-19, Volume: 374, Issue:9694 Topics: Administration, Inhalation; Adult; Anti-Inflammatory Agents; Antiviral Agents; Bronchoalveolar Lavage Fluid; Critical Care; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Infusions, Intravenous; Methylprednisolone; Neutropenia; Pneumonia, Viral; Treatment Outcome; Viral Load; Zanamivir	2009
An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia. Pediatric pulmonology, 2010, Volume: 45, Issue:7 Topics: Antiviral Agents; Fever; Gentamicins; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Zanamivir	2010
[Influenza A H1N1v treated with extracorporeal membrane oxygenation]. Ugeskrift for laeger, 2010, Aug-23, Volume: 172, Issue:34 Topics: Adult; Antiviral Agents; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pneumonia, Viral; Zanamivir	2010
[Etiotropic therapy of influenza: lessons from the last pandemic]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2011, Issue:5 Topics: Antiviral Agents; Communicable Diseases, Emerging; Drug Resistance, Viral; Early Diagnosis; Hemagglutination, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir; Pandemics; Pneumonia, Viral; Prognosis; Severity of Illness Index; Viral Interference; Viral Tropism; Zanamivir	2011
Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus. Singapore medical journal, 2011, Volume: 52, Issue:7 Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Oseltamivir; Pneumonia, Viral; Singapore; Survival Analysis; Zanamivir	2011
Compared protective effect of nasal immunoprophylaxis using a new human monoclonal IgM antibody, human polyclonal antibodies, F(ab')2, amantadine, and zanamivir for prophylaxis of influenza A virus pneumonia in mice. Military medicine, 2003, Volume: 168, Issue:3 Topics: Amantadine; Animals; Antibodies, Monoclonal; Antiviral Agents; Female; Guanidines; Humans; Immunization, Passive; Immunoglobulin Fab Fragments; Immunoglobulin M; Immunoglobulins, Intravenous; Influenza A virus; Influenza, Human; Mice; Mice, Inbred BALB C; Pneumonia, Viral; Pyrans; Sialic Acids; Zanamivir	2003
Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus. Antiviral therapy, 2007, Volume: 12, Issue:4 Topics: Antiviral Agents; Bone Marrow Transplantation; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Pneumonia, Viral; Recurrence; Treatment Failure; Zanamivir	2007